ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 730870 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 730870; 2) Community: the network communities that were significantly associated with the response to NSC 730870; 3) Molecule: the relationships between components within communities and NSC 730870; 4) MDR: the compounds that were significantly associated with the NSC 730870.

NSC Compound Enrichment Correlation
NSC 18300 Null 0.00617256681787881 -0.10669311
NSC 305802 2,4-Quinazolinediamine, 5,6,7,8-tetrahydro-6-(2-naphthalenylsulfonyl)- 0.00617256681787881 0.239001
NSC 43101 Null 0.00617256681787881 -0.014963571
NSC 703784 L-Lysinamide, N-[4-(1,3-benzothiazol-2-yl)phenyl-2-chlorophenyl]-,dihydrochloride 0.00617256681787881 0.01758624
NSC 709358 1H-Pyrrole-2-carboxamide, N-[3-(dimethylamino)propyl]-1-methyl-4-[[[1-methyl- 4-[[1-oxo-4-[[(2,3,5,11a-tetrahydro-7-methoxy-5-oxo- 1H-pyrrolo[2,1-c][1,4]benzodiazepin-8-yl]oxy]butyl]amino]- 1H-pyrrol 0.00617256681787881 0.15033231
NSC 281245 COMPACTIN 0.00705866970012644 -0.1061264
NSC 30706 2,5-Di(ethyleneimino)-1,4-benzoquinone 0.00705866970012644 0.19659268
NSC 352299 2-methylellpticinium 0.00705866970012644 0.10265989
NSC 363979 Cephalostatin 1 0.00705866970012644 0.12292545
NSC 677942 L-Glutamamide, N(2)-[4-[[(2,4-diamino-6-pteridinyl)methyl](methyl)amino]benzoyl]-N(1),N(5)-didecyl- 0.00705866970012644 0.12746238
Total:29  Current:3    [First] [Prev] [Next] [Last]